Form 4 · MDT
Medtronic CEO Geoffrey Martha reports selling 50,000 shares under a 10b5-1 plan
Geoffrey Martha, Medtronic's Chairman and CEO, a director, filed a Form 4 on Oct 16, 2026 at 6:00 PM ET reporting transactions on Oct 15, 2026.
The filing reports 50,000 shares in an open-market or private sale (code S) at $95.00, about $4.8 million in total.
The filing says the sales were made under a Rule 10b5-1 trading plan.
After these transactions, the filing lists 277,866 shares of Ordinary Shares held directly.
Effect on holdings
Taken together, the rows reported here lowered Geoffrey Martha's directly held shares by 15.3%, from 327,866 to 277,866.
Reporting person
- Geoffrey Martha, Chairman and CEO, a director (as filed: Martha Geoffrey)
Transactions as reported
| Date | Code | Security | Shares | Price | Acquired or disposed | Held after | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-10-15 | S | Ordinary Shares | 50,000 | $95.00 | Disposed | 277,866 | Direct |
Codes: P purchase, S sale, A grant or award, M/X/C exercise or conversion, F shares withheld for taxes or the exercise price, G gift. Prices are as reported; some are weighted averages of several trades.
Source
- Form 4 filed Oct 16, 2026 (document)
- Filing index on SEC EDGAR (all documents and exhibits)
Medtronic company file → · More Medtronic filings
Disclosures
- Editor holdings in MDT
- The editor holds no position in Medtronic (MDT). As of Oct 25, 2026.
- Last updated
- Oct 25, 2026
A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold MDT.